Invention Grant
- Patent Title: Aminoindazole derivatives as sodium channel inhibitors
-
Application No.: US15559120Application Date: 2016-03-22
-
Publication No.: US10173985B2Publication Date: 2019-01-08
- Inventor: Laia Sole Feu , Silvia Fonquerna Pou
- Applicant: ALMIRALL, S.A.
- Applicant Address: ES Barcelona
- Assignee: Almirall, S.A.
- Current Assignee: Almirall, S.A.
- Current Assignee Address: ES Barcelona
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP15382139 20150324
- International Application: PCT/EP2016/056273 WO 20160322
- International Announcement: WO2016/150971 WO 20160929
- Main IPC: C07D231/56
- IPC: C07D231/56 ; C07D401/04 ; C07D405/10 ; C07D471/04 ; C07D487/04 ; A61K31/416 ; A61K45/06 ; A61K31/454 ; A61K31/4545 ; A61K31/437 ; A61K31/4985 ; A61K31/5377 ; A61K31/4439
Abstract:
The present invention relates to novel aminoindazolyl derivative compounds of Formula (I), the use of said compounds in treating diseases mediated by modulation of voltage-gated sodium channels in particular Nav 1.7, to compositions containing said derivatives and processes for their preparation.
Public/Granted literature
- US20180244626A1 AMINOINDAZOLE DERIVATIVES AS SODIUM CHANNEL INHIBITORS Public/Granted day:2018-08-30
Information query
